相关实验视频
Updated: May 12, 2026

07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
36.7K
针对单源性脏病的单源性疾病 (PGT-M) 的植入前遗传检测:单中心回顾性队列分析
Xinyu Liu1,2,3,4,5,6,7, Qian Zhang1,2,3,4,5,6,7, Kexin Cao1,2,3,4,5,6,7
1State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong, China.
Clinical kidney journal
|January 13, 2025
概括
针对单一性疾病的植入前遗传检测 (PGT-M) 有效地防止遗传性病的传播. 产前诊断证实了健康的新生儿,验证了PGT-M对患脏疾病风险的夫妇的验证.
科学领域:
- 生殖医学 生殖医学
- 医学遗传学 医学遗传学
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 遗传性病会导致严重的功能衰竭和末期病.
- 对于受影响的夫妇来说,防止单源性病向后代传播至关重要.
- 针对单一性疾病的植入前遗传检测 (PGT-M) 通过对胚胎进行查提供了一个解决方案.
研究的目的:
- 提供PGT-M接受单一性脏病患者的临床概述.
- 评估PGT-M在预防遗传性病遗传方面的有效性.
主要方法:
- 一个单一中心的回顾性队列研究,从2014年到2022年对352对患有病相关疾病的夫妇进行了研究.
- 104对具有单一性脏病征兆的夫妇接受了PGT-M,涉及囊胚活检和遗传检测.
- 进行了80个玻璃化解的单芽细胞转移周期.
主要成果:
- 在接受PGT-M的104对夫妇中,80个转移周期导致38个活产.
- 其中37个活产是来自具有非致病性基因型的胚胎.
- 随访的入侵性产前诊断证实了PGT-M在18名活产儿的结果.
结论:
- PGT-M是一种有效的策略,可以防止单一性脏病的代际遗传.
- PGT-M结果与产前诊断之间的一致性支持其在确保健康后代方面的有效性.
相关概念视频
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

